Av kontakt [at] artrosportalen [dot] se (Artrosportalen) - publicerad 17 oktober 2022 Forskare har tittat på om gång som träningsform kan minska risken för knäsmärta och om det kan leda till strukturella skillnader som ses med hjälp av röntgenbilder. I en amerikansk studie har forskare studerat huruvida gång som träningsform kan ha någon koppling till knäartrosens progress såväl när det kommer til

https://www.artrosportalen.lu.se/artikel/kan-knasmarta-minskas-med-hjalp-av-gang - 2025-07-09

Av kontakt [at] artrosportalen [dot] se (Artrosportalen) - publicerad 24 oktober 2022 I en ny studie har 60 000 svenska tvillingar studerats. Forskare har undersökt vilken roll genetiska faktorer spelar i utvecklingen av handartros. Den genetiska faktorn verkar vara starkt bidragande till att en vid besök hos specialistvården blir diagnosticerad med handartros. I studien jämförde forskarna förekom

https://www.artrosportalen.lu.se/artikel/genetik-kan-forklara-varfor-manga-drabbas-av-handartros - 2025-07-09

Av kontakt [at] artrosportalen [dot] se (Artrosportalen) - publicerad 11 november 2022 Forskare har studerat vad som avhjälper smärta vid knä- och höftartros bäst, fysiska vårdbesök eller en digital tjänst. I en ny svensk studie har forskare tittat närmre på vad som avhjälper smärta vid knä- och höftartros bäst, fysiska vårdbesök eller digital vård. Den digitala vården erhölls i studien genom tjän

https://www.artrosportalen.lu.se/artikel/artrossmarta-kan-avhjalpas-saval-fysiska-som-digitala-vardtjanster - 2025-07-09

Av kontakt [at] artrosportalen [dot] se (Artrosportalen) - publicerad 21 november 2022 I en ny studie som publicerats i The British Journal of Sports Medicine, utmanas det vanliga antagandet om att en främre korsbandsskada inte kan läka av sig själv. Det främre korsbandet (på engelska ofta förkortat ACL) är det ligament som huvudsakligen stabiliserar knäet. Bristningar i det främre korsbandet ses

https://www.artrosportalen.lu.se/artikel/ny-studie-visar-att-bristning-i-framre-korsbandet-kan-laka-utan-operation - 2025-07-09

Av kontakt [at] artrosportalen [dot] se (Artrosportalen) - publicerad 27 november 2022 Vi följer Amanda Sjögren under hennes tid som doktorand och tar reda på mer om vad hennes jobb innebär och vad målet med hennes forskning är. Forskning sker på många olika nivåer och en forskare börjar ofta sin resa som doktorand. Tidigare i år började Amanda Sjögren som doktorand hos oss vid enheten för klinisk

https://www.artrosportalen.lu.se/artikel/reportage-folj-doktoranden-som-vill-bidra-till-artrosforskning-pa-molekylar-niva - 2025-07-09

Av kontakt [at] artrosportalen [dot] se (Artrosportalen) - publicerad 9 januari 2023 Detta är andra delen av reportageserien där vi följer Amanda Sjögren, doktorand vid Lunds universitet. Vi följer Amanda Sjögren under hennes tid som doktorand vid Lunds universitet. Har du missat första delen hittar du den genom att klicka här. Amanda berättar att hon tycker det är intressant att arbeta med artros

https://www.artrosportalen.lu.se/artikel/reportage-andra-delen-om-doktoranden-som-vill-bidra-till-artrosforskning-pa-molekylar-niva - 2025-07-09

By kontakt [at] artrosportalen [dot] se (The Arthritis Portal) - published 23 June 2021 In a new Swedish study by Lund University on comorbidities in osteoarthritis, researchers studied if people with osteoarthritis are at an increased risk for cancer compared to people without osteoarthritis. The study focused on the four most common cancer types, lung, colon, breast, and prostate cancer. Researc

https://www.arthritisportal.lu.se/article/oa-linked-cancer - 2025-07-09

By kontakt [at] artrosportalen [dot] se (The Arthritis Portal) - published 31 August 2021 Previous studies from Iceland have shown how osteoarthritis is often inherited and can be traced back several generations. A gene (genetic predisposition) is a segment of DNA containing hereditary information and is inherited from our biological parents. A new international study published in the high-ranking

https://www.arthritisportal.lu.se/article/your-genes-play-part-development-oa-and-perceived-joint-pain - 2025-07-09

By kontakt [at] artrosportalen [dot] se (The Arthritis Portal) - published 26 August 2021 Devil's Claw (Harpagophytum procumbens) is a plant in the sesame family native South Africa that has long been used as a herbal medicine to treat a number of different diseases. The plant is believed to be able to reduce joint pain and joint stiffness as it is said to have analgesic and anti-inflammatory prop

https://www.arthritisportal.lu.se/article/devils-claw-herbal-medicine-continued-uncertain-effect-oa-pain - 2025-07-09

Published 2 June 2021 Osteoarthritis has been described as the 15th most common cause of so-called “years lived with disability” (YLDs) in the world, which is a measure used to shed light on the burden of various diseases on society. According to the researchers, the economic costs caused by the disease correspond to about 1-2.5% of the gross domestic product (GDP) in most countries. A new article

https://www.arthritisportal.lu.se/article/global-burden-osteoarthritis - 2025-07-09

By kontakt [at] artrosportalen [dot] se (The Arthritis Portal) - published 11 June 2021 In a new Swedish study by Lund University, researchers looked at how common it is with comorbidities in osteoarthritis of the knee and/or hip. The study was published in the American journal Arthritis Care & Research. The study analyzed data collected from the province of Scania's population between the years 1

https://www.arthritisportal.lu.se/article/common-comorbidities-osteoarthritis - 2025-07-09

By kontakt [at] artrosportalen [dot] se (The Arthritis Portal) - published 29 October 2021 Earlier in October, we reported on a research study that showed that platelet-rich plasma (PRP) injections for treating osteoarthritis of the knee did not have a better effect on OA symptoms than placebo. Last week, results from a new study on PRP were published. The researchers concluded that PRP injections

https://www.arthritisportal.lu.se/article/effect-prp-ankle-oa-no-better-placebo - 2025-07-09

By kontakt [at] artrosportalen [dot] se (The Arthritis Portal) - published 19 October 2021 The painkiller tanezumab was not approved by the European Medicine's Agency. At the beginning of 2021, news came that tanezumab, a new pain medication, would be launched in the US and Europe.  However, in March, tanezumab suffered a setback in the United States when the US Food and Drug Administration reject

https://www.arthritisportal.lu.se/article/not-approved-eu-another-setback-drug-tanezumab - 2025-07-09

By kontakt [at] artrosportalen [dot] se (The Arthritis Portal) - published 27 October 2021 Tramadol is an increasingly common drug prescribed for pain. Tramadol is a synthetic opioid (manufactured in a lab) that differs somewhat in its chemical structure compared to the natural opioid codeine. Other opioids include morphine and heroin. All opioids have analgesic properties and are extremely addict

https://www.arthritisportal.lu.se/article/many-risks-painkiller-tramadol - 2025-07-09

By kontakt [at] artrosportalen [dot] se (The Arthritis Portal) - published 18 October 2021 In a new meta-analysis (a compilation of results from a number of different research studies), the benefits and side effects of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), paracetamol, and opioids have been studied. The research study included data from 181 publications describing 192 clinical trials inv

https://www.arthritisportal.lu.se/article/benefits-and-side-effects-common-pain-meds-osteoarthritis-knee-and-hip - 2025-07-09

By kontakt [at] artrosportalen [dot] se (The Arthritis Portal) - published 15 September 2021 A Chinese research group has compiled data from 88 different scientific studies on the prevalence of knee osteoarthritis. The studies were from all around the world and together included more than 10 million people. The researchers estimated that for individuals aged 40 years and older, the global prevalen

https://www.arthritisportal.lu.se/article/how-common-knee-osteoarthritis - 2025-07-09

By kontakt [at] artrosportalen [dot] se (The Arthritis Portal) - published 4 October 2021 PRP treatment (platelet-rich plasma) is a relatively new experimental treatment that is often marketed to be effective for patients with osteoarthritis. However, there is a lack of high-quality research claiming the effectiveness of the treatment. Researchers from Brazil have recently published results from a

https://www.arthritisportal.lu.se/article/prp-injections-no-more-effective-placebo - 2025-07-09

By kontakt [at] artrosportalen [dot] se (The Arthritis Portal) - published 24 November 2021 Doctors Jack Cush, Martin Englund, Gillian Hawker, Tihuna Neogi, and Kent Kwoh discuss the best OA research from the 2021 ACR (American College of Rheumatology) conference, including a new study indicating that the diabetes medicine metformin lowers the risk of developing osteoarthritis. Dr. Jack Cush is a

https://www.arthritisportal.lu.se/article/osteoarthritis-roundtable-best-acr-conference-2021 - 2025-07-09

By kontakt [at] artrosportalen [dot] se (Artrosportalen) - published 17 March 2022 In a recent study, a group of scientists have evaluated the burden of osteoarthritis over the past three decades, using data from the worldwide initiative ”Global Burden of Disease study 2019.  The results show that the number of people affected by osteoarthritis has increased by about 113 percent in 30 years, from

https://www.arthritisportal.lu.se/article/increased-burden-osteoarthritis-world - 2025-07-09

By kontakt [at] artrosportalen [dot] se (Artrosportalen) - published 25 April 2022 Researchers from Australia have investigated the incidence of obesity in patients with OA undergoing knee replacement. In a recent study from Australia researchers have investigated the incidence of obesity in patients undergoing knee replacements because of their OA. The results were compared to the incidence of ob

https://www.arthritisportal.lu.se/article/there-link-between-oa-and-obesity - 2025-07-09